The University of Florida Department of Urology invites you to attend
“Testosterone and Prostate Cancer: Past, Present, and Future“
Jonathan Pavlinec, MD
Department of Urology
University of Florida
Wednesday, April 20, 2016
Department of Urology Conference Room
Evaluate historical context of testosterone and hormonal nature of prostate cancer (PCa)
Review the “Androgen Hypothesis,” and flaws exposed by the literature
Understand implications of the “Saturation Model”
Discuss benefits of testosterone therapy (TTh) in hypogonadal men
Review available data evaluating TTh and risk of Pca
Discuss recent data on TTh in men with history of PCa
Appreciate current studies of TTh with PCa on Active Surveillance
Introduce concept of Bipolar Androgen Therapy
Review FDA warning on TTh and barriers to paradigm shift from historical views
Present current guidelines on TTh as related to surveillance and risk of PCa
Urologists, Residents, Nurses, Physician Assistants, and Staff
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
If you have any questions please feel free to contact Chris Emery at email@example.com.
Dr. Pavlinec has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.